Source: Annual Congress 2011 - New mechanisms in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Barta, B. Antus (Budapest, Hungary). Sputum biomarkers in stable COPD. Eur Respir J 2011; 38: Suppl. 55, 705

Member's Comments

No comment yet.

Related content which might interest you: Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Sputum biomarkers of inflammation in smokers and subjects with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 Blood biomarkers in asthma and COPD Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017 Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003 Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Sputum galactomannan in COPD patients with and without bronchiectasis Source: International Congress 2017 – Bronchial asthma management Year: 2017 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Sputum neutrophil monitoring is useful for long-term oxygen therapy in patients with COPD Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Sputum microbiology in patients with stabile COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Sputum proteomics of CF, BE and COPD with or without NTM infections Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Blood eosinophil as a biomarker in COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPD Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012 Proteomic derived biomarkers for COPD are present in induced sputum Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005 Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009